Cargando…
Effect of Sacubitril/Valsartan on Reducing the Risk of Arrhythmia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
BACKGROUND AND OBJECTIVE: Relevant data of PARADIGM-HF reveals sacubitril/valsartan (SV) therapy led to a greater reduction in the risks of arrhythmia, and sudden cardiac death than angiotensin converting enzyme inhibitor (ACEI)/angiotensin receptor inhibitor (ARB) therapy in HFrEF, however, inconsi...
Autores principales: | Wang, Ruxin, Ye, Haowen, Ma, Li, Wei, Jinjing, Wang, Ying, Zhang, Xiaofang, Wang, Lihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289747/ https://www.ncbi.nlm.nih.gov/pubmed/35859597 http://dx.doi.org/10.3389/fcvm.2022.890481 |
Ejemplares similares
-
Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
por: Wang, Ruxin, et al.
Publicado: (2022) -
HADH may be the target molecule of early vascular endothelial impairment in T2DM
por: Ye, Haowen, et al.
Publicado: (2022) -
Effects of different types of radiation therapy on cardiac-specific death in patients with thyroid malignancy
por: Wang, Ruxin, et al.
Publicado: (2022) -
Effect of sacubitril/valsartan on the occurrence of cardiac arrhythmias and the risk of sudden cardiac death in heart failure: A meta-analysis of randomized controlled trials
por: Liu, Xue-Hui, et al.
Publicado: (2022) -
Exploration of Mechanisms of Sacubitril/Valsartan in the Treatment of Cardiac Arrhythmias Using a Network Pharmacology Approach
por: Zhou, Yu, et al.
Publicado: (2022)